Health Care
America has the most advanced health care in the world, in large part due to private sector-led innovation and employer-sponsored healthcare coverage.
While Americans benefit tremendously from ongoing advancements in bioscience, technology, and care, we continue to wrestle with the challenge of making quality health care more affordable, more accessible, and more reliable for all Americans. At the U.S. Chamber, we’re pushing for value-based healthcare solutions that reduce costs and reward quality outcomes.
Latest
Report
The United States is currently grappling with a nursing shortage that is causing a ripple effect of rising health care costs and lower quality of life across the country.
Spotlight on Mental Health
Become a part of the world’s largest business organization and network
U.S. Chamber members range from small businesses and chambers of commerce across the country to startups in fast-growing sectors, leading industry associations, and global corporations.
Discover the ROI Chamber membership can deliver for you.
Our Work
The U.S. Chamber is promoting effective private sector solutions to our health care challenges. These solutions will help control costs, expand access, and improve the quality of care. We support policy that strengthens the employer-based model of coverage, through which 180 million Americans receive—and overwhelmingly like—their health care.
Related Litigation
Events
Latest Content
WASHINGTON, D.C. – This week the U.S. Chamber of Commerce launched a campaign opposing the Administration’s dangerous new proposal, known as Most Favored Nation pricing, which would impose foreign price controls on American drugs. The campaign asks Americans to tell the White House to reject foreign price controls on drugs and keep American innovation strong. Advertising for this effort is running on DC broadcast television, cable news and digital platforms, supported by a seven figure buy.
WASHINGTON, D.C. – U.S. Chamber of Commerce Executive Vice President and Chief Policy Officer Neil Bradley issued the following statement today after the White House issued Executive Orders on drug pricing:
The U.S. bio-pharmaceutical sector is committed to fighting COVID-19, but imposing artificial price controls could impede progress.
Now is a time for common-sense solutions, not radical changes.
Dear Majority Leader McConnell, Speaker Pelosi, Minority Leader Schumer and Minority LeaderMcCarthy,
This Hill letter was sent to the President of the United States Donald Trump, Senate Majority Leader Mitch McConnell, and Speaker of the House Nancy Pelosi.
This Hill letter was sent to the House Committee on Appropriations, on Fiscal Year 2021 Labor, Health and Human Services, Education, and Related Agencies Appropriations.
This joint letter was sent to the President, Vice President, and Governors Hogan and Cuomo expressing concern for current face covering policies.
WASHINGTON, D.C. – Today the U.S. Chamber of Commerce’s U.S.-Israel Business Initiative released a paper entitled “U.S.-Israel Collaboration in Health Innovation” that provides policy recommendations to advance greater coordination in health technology and innovation between the United States and Israel.
Strong intellectual property protections will be important as private industry and government work together to find a cure for COVID-19.
